Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2028
The global biobanking market is projected to reach USD 5.0 billion by 2028 from USD 2.9 billion in 2023, at a CAGR of 11.4% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by the demand for cord blood stem cell preservation. The increasing trend of preserving cord blood stem cells from newborns has led to a significant increase in the number of cord blood banks and biobanks that specialize in the preservation of cord blood stem cells. These biobanks store cord blood samples for long-term use and provide services, and are a valuable resource for researchers and clinicians studying regenerative medicine.
“The consumables segment accounted for the second-largest share by product during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product in the global biobanking market. Biobanking consumables primarily include reagents and media, nucleic acid extraction kits, surface disinfectants, collection kits, swabs, containers, and syringes. Consumables are indispensable and integral components of biobanking. With the rising demand for the biobanking of cells, tissues, and organs, the requirement for biobanking equipment and consumables has increased significantly. Furthermore, there is a growing demand for storage equipment in the biobanking industry, with an increasing number of samples being stored for research and clinical applications. These trends underscore the importance of reliable and effective storage consumables in maintaining the integrity and accessibility of valuable biological specimens
“Europe: The second largest region in the biobanking market”
Europe is the second-largest market for biobanking after North America. The European biobanking market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. One notable factor is the increasing focus on personalized medicine and precision healthcare, which has created a burgeoning demand for high-quality biological samples and associated data. Furthermore, the advancements in genomic research and the advent of next-generation sequencing technologies have stimulated the need for vast repositories of biological materials, fueling the growth of biobanking activities across Europe. This upward trajectory in the European biobanking market exemplifies its vital role in facilitating biomedical research, enabling the development of innovative diagnostics, therapies, and treatments for improved patient outcomes
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the biobanking market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, sample type, storage type, ownership, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
“The consumables segment accounted for the second-largest share by product during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product in the global biobanking market. Biobanking consumables primarily include reagents and media, nucleic acid extraction kits, surface disinfectants, collection kits, swabs, containers, and syringes. Consumables are indispensable and integral components of biobanking. With the rising demand for the biobanking of cells, tissues, and organs, the requirement for biobanking equipment and consumables has increased significantly. Furthermore, there is a growing demand for storage equipment in the biobanking industry, with an increasing number of samples being stored for research and clinical applications. These trends underscore the importance of reliable and effective storage consumables in maintaining the integrity and accessibility of valuable biological specimens
“Europe: The second largest region in the biobanking market”
Europe is the second-largest market for biobanking after North America. The European biobanking market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. One notable factor is the increasing focus on personalized medicine and precision healthcare, which has created a burgeoning demand for high-quality biological samples and associated data. Furthermore, the advancements in genomic research and the advent of next-generation sequencing technologies have stimulated the need for vast repositories of biological materials, fueling the growth of biobanking activities across Europe. This upward trajectory in the European biobanking market exemplifies its vital role in facilitating biomedical research, enabling the development of innovative diagnostics, therapies, and treatments for improved patient outcomes
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side 20%
- By Designation: C-level - 45%, D-level - 30%, and Others - 25%
- By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
- Thermo Fisher Scientific, Inc. (US)
- PHC Holdings Corporation (Japan)
- Becton, Dickinson and Company (US)
- QIAGEN N.V. (Germany)
- Merck KGaA (Germany)
- Avantor, Inc. (US)
- Cryoport, Inc. (US)
- Tecan Trading AG (Switzerland)
- Azenta, Inc. (US)
- Greiner Holding AG (Austria)
- Hamilton Company (US)
- Micronic (Netherlands)
- AMSBIO (UK)
- Bay Biosciences LLC (US)
- BioKryo (Germany)
- SPT Labtech (UK)
- ASKION GmbH (Germany)
- Cell&Co BioServices (France)
- Ziath Ltd. (UK)
- CTIBiotech (France)
- Cureline (US)
- Firalis Group (France)
- Sopachem (Netherlands)
- ProteoGenex (US)
- US Biolab Corporation, Inc. (US)
This report provides a detailed picture of the biobanking market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, sample type, storage type, ownership, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
- Analysis of key drivers (growing investments and funding for biobanks, focus on genetic testing and precision medicine, increasing trend in preservation of cord blood stem cells from newborns, favorable funding scenario for research related to regenerative medicine), restraints (High cost of automated equipment, issues related to biospecimen sample management), opportunities (emerging countries to provide lucrative opportunities), and challenges (high operational cost of biobanks, storage of samples) influencing the growth of the market.
- Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the biobanking market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biobanking market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US) and among others in the market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF ECONOMIC RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 2 BIOBANKING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 3 MARKET SIZE ESTIMATION - COMPANY REVENUE ANALYSIS (2022)
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 4 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 5 BIOBANKING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 6 BIOBANKING MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION ON BIOBANKING MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024?2027
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 9 BIOBANKING MARKET, BY STORAGE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 BIOBANKING MARKET, BY SAMPLE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BIOBANKING MARKET, BY OWNERSHIP, 2023 VS. 2028 (USD MILLION)
FIGURE 12 BIOBANKING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 BIOBANKING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BIOBANKING MARKET
4 PREMIUM INSIGHTS
4.1 BIOBANKING MARKET OVERVIEW
FIGURE 15 GROWING INVESTMENTS AND FUNDING FOR BIOBANKS TO DRIVE MARKET
4.2 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE AND COUNTRY (2022)
FIGURE 16 MANUAL STORAGE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN BIOBANKING MARKET IN 2022
4.3 BIOBANKING MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 REGENERATIVE MEDICINE SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028
4.4 BIOBANKING MARKET SHARE, BY END USER (2023)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 BIOBANKING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing investments and funding for biobanks
5.2.1.2 Focus on genetic testing and precision medicine
5.2.1.3 Increasing trend in preservation of cord blood stem cells from newborns
5.2.1.4 Favorable funding scenario for research related to regenerative medicine
5.2.2 RESTRAINTS
5.2.2.1 High cost of automated equipment
5.2.2.2 Issues related to biospecimen sample management
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies to provide lucrative opportunities
5.2.4 CHALLENGES
5.2.4.1 High operational cost of biobanks
5.2.4.2 Storage of samples
5.3 RANGES/SCENARIOS
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOBANKING PRODUCT PROVIDERS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
TABLE 3 PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER
5.5.2 AVERAGE SELLING PRICE TREND
5.6 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS OF BIOBANKING MARKET
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 24 BIOBANKING MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 25 ECOSYSTEM ANALYSIS: BIOBANKING MARKET
TABLE 4 SUPPLY CHAIN ECOSYSTEM
5.9 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR BIOBANKING MARKET, JANUARY 2013–APRIL 2023
5.10 KEY CONFERENCES AND EVENTS IN 2023
TABLE 5 BIOBANKING MARKET: LIST OF CONFERENCES AND EVENTS
5.11 REGULATORY ANALYSIS
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOBANKING PRODUCTS
5.13.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS AMONG END USERS
FIGURE 28 KEY BUYING CRITERIA FOR END USERS
6 BIOBANKING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 7 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 EQUIPMENT
TABLE 8 BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 9 BIOBANKING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 10 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 11 EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 12 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 13 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 STORAGE EQUIPMENT
6.2.1.1 Storage solutions for biobanking to ensure integrity and longevity of biological samples
TABLE 14 STORAGE EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 SAMPLE ANALYSIS EQUIPMENT
6.2.2.1 Ensures sample integrity, traceability, and preservation
TABLE 19 SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 SAMPLE PROCESSING EQUIPMENT
6.2.3.1 Demand for reliable biobanking equipment to propel adoption
TABLE 24 SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 SAMPLE TRANSPORT EQUIPMENT
6.2.4.1 Need for reliable transport equipment to maintain sample integrity and quality to drive market
TABLE 29 SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 CONSUMABLES
TABLE 34 BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 BIOBANKING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 STORAGE CONSUMABLES
6.3.1.1 Play crucial role in preserving integrity and viability of samples
TABLE 40 STORAGE CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 ANALYSIS CONSUMABLES
6.3.2.1 Increasing demand for sample analysis to fuel adoption
TABLE 45 ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 PROCESSING CONSUMABLES
6.3.3.1 Use of sample processing consumables for efficient biobanking to drive growth
TABLE 50 PROCESSING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 COLLECTION CONSUMABLES
6.3.4.1 Demand for efficient sample handling to drive adoption
TABLE 55 COLLECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 LATIN AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
TABLE 60 BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 61 BIOBANKING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 STORAGE SERVICES
6.4.1.1 Increasing number of biological samples to fuel demand for storage services
TABLE 66 STORAGE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 LATIN AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 PROCESSING SERVICES
6.4.2.1 Critical for preparation of samples for storage and analysis
TABLE 71 PROCESSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.3 TRANSPORT SERVICES
6.4.3.1 Help in facilitating biobanking operations
TABLE 76 TRANSPORT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.4 SUPPLY SERVICES
6.4.4.1 Supply services for biobanking to enable research and discovery
TABLE 81 SUPPLY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SOFTWARE
6.5.1 RISING ADOPTION OF BIOBANKING SOFTWARE TO MANAGE BIOLOGICAL SAMPLES TO DRIVE GROWTH
TABLE 86 BIOBANKING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 BIOBANKING MARKET, BY STORAGE TYPE
7.1 INTRODUCTION
TABLE 91 BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
7.2 MANUAL STORAGE
7.2.1 POPULARITY OF MANUAL STORAGE OVER AUTOMATED STORAGE TO SUPPORT MARKET GROWTH
TABLE 92 BIOBANKING MARKET FOR MANUAL STORAGE, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 EUROPE: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 AUTOMATED STORAGE
7.3.1 EFFICIENT TRACKING OF SAMPLES AND REDUCTION OF MANUAL ERRORS TO DRIVE MARKET
TABLE 97 BIOBANKING MARKET FOR AUTOMATED STORAGE, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 LATIN AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
8 BIOBANKING MARKET, BY SAMPLE TYPE
8.1 INTRODUCTION
TABLE 102 BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
8.2 BLOOD PRODUCTS
8.2.1 USE IN WIDE RANGE OF APPLICATIONS TO PROPEL MARKET
TABLE 103 BIOBANKING MARKET FOR BLOOD PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HUMAN TISSUES
8.3.1 PIVOTAL ROLE IN FACILITATING SCIENTIFIC DISCOVERIES AND IMPROVING PATIENT CARE TO DRIVE MARKET
TABLE 108 BIOBANKING MARKET FOR HUMAN TISSUES, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 CELL LINES
8.4.1 SERVE AS VALUABLE RESOURCES IN BIOBANKING
TABLE 113 BIOBANKING MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 NUCLEIC ACIDS
8.5.1 GROWING DEMAND FOR STORAGE AND ANALYSIS OF NUCLEIC ACIDS TO DRIVE MARKET
TABLE 118 BIOBANKING MARKET FOR NUCLEIC ACIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 LATIN AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 BIOLOGICAL FLUIDS
8.6.1 SERVE AS VALUABLE RESOURCES FOR RESEARCHERS AND CLINICIANS IN STUDYING DISEASES
TABLE 123 BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 HUMAN WASTE PRODUCTS
8.7.1 USE OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET
TABLE 128 BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
9 BIOBANKING MARKET, BY OWNERSHIP
9.1 INTRODUCTION
TABLE 133 BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
9.2 UNIVERSITIES
9.2.1 IMPORTANCE OF BIOBANKING IN ADVANCING RESEARCH TO DRIVE MARKET
TABLE 134 UNIVERSITY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NATIONAL/REGIONAL AGENCIES
9.3.1 SUSTAINED FUNDING AND STANDARDIZED PRACTICES TO SUPPORT MARKET GROWTH
TABLE 139 NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 140 NORTH AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 141 EUROPE: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 ASIA PACIFIC: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 LATIN AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 NON-PROFIT ORGANIZATIONS
9.4.1 FOCUS OF NON-PROFIT ORGANIZATIONS ON ADVANCING RESEARCH TO DRIVE MARKET
TABLE 144 NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 145 NORTH AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 146 EUROPE: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 ASIA PACIFIC: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 PRIVATE ORGANIZATIONS
9.5.1 INCREASING OWNERSHIP OF BIOBANKS BY PRIVATE ORGANIZATIONS TO DRIVE MARKET
TABLE 149 PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 150 NORTH AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 151 EUROPE: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 ASIA PACIFIC: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10 BIOBANKING MARKET, BY APPLICATION
10.1 INTRODUCTION
TABLE 154 BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10.2 REGENERATIVE MEDICINE
10.2.1 INCREASING RESEARCH AND RISING GOVERNMENT FUNDING TO DRIVE MARKET
TABLE 155 BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 LIFE SCIENCE RESEARCH
10.3.1 INCREASING DEMAND AND UTILIZATION OF BIOBANKS IN LIFE SCIENCE RESEARCH APPLICATIONS TO SUPPORT MARKET GROWTH
FIGURE 29 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
TABLE 160 BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 LATIN AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 CLINICAL RESEARCH
10.4.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND ACCELERATED DRUG DEVELOPMENT TO PROPEL MARKET
TABLE 165 BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
11 BIOBANKING MARKET, BY END USER
11.1 INTRODUCTION
TABLE 170 BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
11.2.1 LARGEST END USER SEGMENT DUE TO GROWING NUMBER OF CLINICAL TRIALS AND RESEARCH STUDIES
TABLE 171 BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ACADEMIC AND RESEARCH INSTITUTES
11.3.1 ADVANCEMENTS IN SCIENTIFIC RESEARCH AND INNOVATION TO DRIVE MARKET
TABLE 176 BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 178 EUROPE: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 HOSPITALS
11.4.1 USE BIOBANKING TO COLLECT, STORE, AND MANAGE PATIENT SAMPLES FOR DIAGNOSTIC PURPOSES
TABLE 181 BIOBANKING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 182 NORTH AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 183 EUROPE: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 ASIA PACIFIC: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
12 BIOBANKING MARKET, BY REGION
12.1 INTRODUCTION
TABLE 186 BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
12.2.1 RECESSION IMPACT
FIGURE 30 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT
TABLE 187 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 NORTH AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 189 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 193 NORTH AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 194 NORTH AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 195 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 196 NORTH AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.2 US
12.2.2.1 Largest market in North America due to surge in genomic research
TABLE 197 US: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 198 US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 US: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 US: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 US: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 202 US: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 203 US: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 204 US: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 205 US: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.3 CANADA
12.2.3.1 Increasing number of biobanks to support market
TABLE 206 CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 CANADA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 211 CANADA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 212 CANADA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 213 CANADA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 214 CANADA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3 EUROPE
12.3.1 RECESSION IMPACT
TABLE 215 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 221 EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 222 EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 223 EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Largest market for biobanking in Europe
TABLE 225 GERMANY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 226 GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GERMANY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 GERMANY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 230 GERMANY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 231 GERMANY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 232 GERMANY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 233 GERMANY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 UK
12.3.3.1 Increasing number of biobanks to support market growth
TABLE 234 UK: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 235 UK: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 UK: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 237 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 238 UK: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 239 UK: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 240 UK: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 241 UK: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 UK: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 FRANCE
12.3.4.1 Robust healthcare infrastructure and advanced research capabilities to propel market
TABLE 243 FRANCE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 244 FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 245 FRANCE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 246 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 FRANCE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 248 FRANCE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 249 FRANCE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 250 FRANCE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 251 FRANCE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 ITALY
12.3.5.1 Emergence of private sector players to support market growth
TABLE 252 ITALY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 ITALY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 ITALY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 257 ITALY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 258 ITALY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 259 ITALY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 260 ITALY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.6 SPAIN
12.3.6.1 Favorable government initiatives to propel market
TABLE 261 SPAIN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 262 SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 SPAIN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 264 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 SPAIN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 266 SPAIN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 267 SPAIN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 268 SPAIN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 269 SPAIN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.7 REST OF EUROPE
TABLE 270 REST OF EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 271 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 REST OF EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 274 REST OF EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 275 REST OF EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 276 REST OF EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 277 REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 278 REST OF EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4 ASIA PACIFIC
12.4.1 RECESSION IMPACT
FIGURE 31 ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT
TABLE 279 ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 280 ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 281 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 285 ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 286 ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 287 ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 288 ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.2 CHINA
12.4.2.1 Advanced healthcare infrastructure and increasing investments in medical research to propel market
TABLE 289 CHINA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 290 CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 CHINA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 293 CHINA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 294 CHINA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 295 CHINA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 296 CHINA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 297 CHINA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 JAPAN
12.4.3.1 Advancements in medical research and increasing need for personalized medicine to drive market
TABLE 298 JAPAN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 299 JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 300 JAPAN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 JAPAN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 303 JAPAN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 304 JAPAN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 305 JAPAN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 306 JAPAN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 INDIA
12.4.4.1 Demand for high-quality biological samples for medical research and development to drive market
TABLE 307 INDIA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 308 INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 INDIA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 INDIA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 312 INDIA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 313 INDIA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 314 INDIA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 315 INDIA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 REST OF ASIA PACIFIC
TABLE 316 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 317 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5 LATIN AMERICA
12.5.1 RECESSION IMPACT
TABLE 325 LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 326 LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 327 LATIN AMERICA BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 328 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 329 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 330 LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 331 LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 332 LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 333 LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 334 LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.2 BRAZIL
12.5.2.1 Advancements in research capabilities to favor market growth
TABLE 335 BRAZIL: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 336 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 BRAZIL: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 339 BRAZIL: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 340 BRAZIL: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 341 BRAZIL: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 342 BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 343 BRAZIL: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 344 REST OF LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 345 REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 346 REST OF LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 347 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 348 REST OF LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 349 REST OF LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 350 REST OF LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 351 REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 352 REST OF LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
12.6.1 INCREASING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET
12.6.2 RECESSION IMPACT
TABLE 353 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 356 MIDDLE EAST & AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 357 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 358 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 359 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 360 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 361 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 KEY PLAYER STRATEGIES IN BIOBANKING MARKET, JANUARY 2020–APRIL 2023
13.3 MARKET SHARE ANALYSIS
FIGURE 33 BIOBANKING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 362 BIOBANKING MARKET: DEGREE OF COMPETITION
13.4 REVENUE SHARE ANALYSIS
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 35 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT, 2022
13.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 36 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2022
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
TABLE 363 BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 364 BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
13.7.1 COMPANY FOOTPRINT ANALYSIS
TABLE 365 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS
13.7.2 END USER FOOTPRINT ANALYSIS
TABLE 366 END USER FOOTPRINT ANALYSIS OF KEY PLAYERS
13.7.3 REGIONAL FOOTPRINT ANALYSIS
TABLE 367 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
13.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 368 BIOBANKING MARKET: DEALS, JANUARY 2020–APRIL 2023
TABLE 369 BIOBANKING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020–APRIL 2023
TABLE 370 BIOBANKING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
14.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 371 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
14.1.2 PHC HOLDINGS CORPORATION
TABLE 372 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 38 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
14.1.3 BECTON, DICKINSON AND COMPANY
TABLE 373 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
14.1.4 QIAGEN N.V.
TABLE 374 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
14.1.5 MERCK KGAA
TABLE 375 MERCK KGAA: COMPANY OVERVIEW
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
14.1.6 AVANTOR, INC
TABLE 376 AVANTOR, INC.: COMPANY OVERVIEW
FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2022)
14.1.7 CRYOPORT, INC.
TABLE 377 CRYOPORT, INC.: COMPANY OVERVIEW
FIGURE 43 CRYOPORT, INC.: COMPANY SNAPSHOT (2022)
14.1.8 TECAN TRADING AG
TABLE 378 TECAN TRADING AG: COMPANY OVERVIEW
FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
14.1.9 AZENTA, INC.
TABLE 379 AZENTA, INC.: COMPANY OVERVIEW
FIGURE 45 AZENTA, INC.: COMPANY SNAPSHOT (2022)
14.1.10 GREINER AG
TABLE 380 GREINER AG: COMPANY OVERVIEW
FIGURE 46 GREINER AG: COMPANY SNAPSHOT (2021)
14.2 OTHER PLAYERS
14.2.1 HAMILTON COMPANY
14.2.2 MICRONIC
14.2.3 AMSBIO
14.2.4 BAY BIOSCIENCES LLC
14.2.5 BIOKRYO
14.2.6 SPT LABTECH
14.2.7 ASKION GMBH
14.2.8 CELL&CO BIOSERVICES
14.2.9 ZIATH LTD.
14.2.10 CTIBIOTECH
14.2.11 CURELINE
14.2.12 FIRALIS GROUP
14.2.13 SOPACHEM
14.2.14 PROTEOGENEX
14.2.15 US BIOLAB CORPORATION, INC.
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF ECONOMIC RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 2 BIOBANKING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 3 MARKET SIZE ESTIMATION - COMPANY REVENUE ANALYSIS (2022)
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 4 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 5 BIOBANKING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 6 BIOBANKING MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION ON BIOBANKING MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024?2027
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 9 BIOBANKING MARKET, BY STORAGE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 BIOBANKING MARKET, BY SAMPLE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BIOBANKING MARKET, BY OWNERSHIP, 2023 VS. 2028 (USD MILLION)
FIGURE 12 BIOBANKING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 BIOBANKING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BIOBANKING MARKET
4 PREMIUM INSIGHTS
4.1 BIOBANKING MARKET OVERVIEW
FIGURE 15 GROWING INVESTMENTS AND FUNDING FOR BIOBANKS TO DRIVE MARKET
4.2 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE AND COUNTRY (2022)
FIGURE 16 MANUAL STORAGE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN BIOBANKING MARKET IN 2022
4.3 BIOBANKING MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 17 REGENERATIVE MEDICINE SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028
4.4 BIOBANKING MARKET SHARE, BY END USER (2023)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 BIOBANKING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing investments and funding for biobanks
5.2.1.2 Focus on genetic testing and precision medicine
5.2.1.3 Increasing trend in preservation of cord blood stem cells from newborns
5.2.1.4 Favorable funding scenario for research related to regenerative medicine
5.2.2 RESTRAINTS
5.2.2.1 High cost of automated equipment
5.2.2.2 Issues related to biospecimen sample management
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies to provide lucrative opportunities
5.2.4 CHALLENGES
5.2.4.1 High operational cost of biobanks
5.2.4.2 Storage of samples
5.3 RANGES/SCENARIOS
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOBANKING PRODUCT PROVIDERS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
TABLE 3 PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER
5.5.2 AVERAGE SELLING PRICE TREND
5.6 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS OF BIOBANKING MARKET
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 24 BIOBANKING MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 25 ECOSYSTEM ANALYSIS: BIOBANKING MARKET
TABLE 4 SUPPLY CHAIN ECOSYSTEM
5.9 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR BIOBANKING MARKET, JANUARY 2013–APRIL 2023
5.10 KEY CONFERENCES AND EVENTS IN 2023
TABLE 5 BIOBANKING MARKET: LIST OF CONFERENCES AND EVENTS
5.11 REGULATORY ANALYSIS
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOBANKING PRODUCTS
5.13.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS AMONG END USERS
FIGURE 28 KEY BUYING CRITERIA FOR END USERS
6 BIOBANKING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 7 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 EQUIPMENT
TABLE 8 BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 9 BIOBANKING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 10 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 11 EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 12 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 13 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 STORAGE EQUIPMENT
6.2.1.1 Storage solutions for biobanking to ensure integrity and longevity of biological samples
TABLE 14 STORAGE EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 SAMPLE ANALYSIS EQUIPMENT
6.2.2.1 Ensures sample integrity, traceability, and preservation
TABLE 19 SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 NORTH AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 EUROPE: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 LATIN AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 SAMPLE PROCESSING EQUIPMENT
6.2.3.1 Demand for reliable biobanking equipment to propel adoption
TABLE 24 SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 25 NORTH AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 EUROPE: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 LATIN AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 SAMPLE TRANSPORT EQUIPMENT
6.2.4.1 Need for reliable transport equipment to maintain sample integrity and quality to drive market
TABLE 29 SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 CONSUMABLES
TABLE 34 BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 BIOBANKING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 STORAGE CONSUMABLES
6.3.1.1 Play crucial role in preserving integrity and viability of samples
TABLE 40 STORAGE CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 ANALYSIS CONSUMABLES
6.3.2.1 Increasing demand for sample analysis to fuel adoption
TABLE 45 ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 PROCESSING CONSUMABLES
6.3.3.1 Use of sample processing consumables for efficient biobanking to drive growth
TABLE 50 PROCESSING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 COLLECTION CONSUMABLES
6.3.4.1 Demand for efficient sample handling to drive adoption
TABLE 55 COLLECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 LATIN AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
TABLE 60 BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 61 BIOBANKING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 STORAGE SERVICES
6.4.1.1 Increasing number of biological samples to fuel demand for storage services
TABLE 66 STORAGE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 LATIN AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 PROCESSING SERVICES
6.4.2.1 Critical for preparation of samples for storage and analysis
TABLE 71 PROCESSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.3 TRANSPORT SERVICES
6.4.3.1 Help in facilitating biobanking operations
TABLE 76 TRANSPORT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.4 SUPPLY SERVICES
6.4.4.1 Supply services for biobanking to enable research and discovery
TABLE 81 SUPPLY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SOFTWARE
6.5.1 RISING ADOPTION OF BIOBANKING SOFTWARE TO MANAGE BIOLOGICAL SAMPLES TO DRIVE GROWTH
TABLE 86 BIOBANKING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 BIOBANKING MARKET, BY STORAGE TYPE
7.1 INTRODUCTION
TABLE 91 BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
7.2 MANUAL STORAGE
7.2.1 POPULARITY OF MANUAL STORAGE OVER AUTOMATED STORAGE TO SUPPORT MARKET GROWTH
TABLE 92 BIOBANKING MARKET FOR MANUAL STORAGE, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 EUROPE: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 AUTOMATED STORAGE
7.3.1 EFFICIENT TRACKING OF SAMPLES AND REDUCTION OF MANUAL ERRORS TO DRIVE MARKET
TABLE 97 BIOBANKING MARKET FOR AUTOMATED STORAGE, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 LATIN AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION)
8 BIOBANKING MARKET, BY SAMPLE TYPE
8.1 INTRODUCTION
TABLE 102 BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
8.2 BLOOD PRODUCTS
8.2.1 USE IN WIDE RANGE OF APPLICATIONS TO PROPEL MARKET
TABLE 103 BIOBANKING MARKET FOR BLOOD PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 HUMAN TISSUES
8.3.1 PIVOTAL ROLE IN FACILITATING SCIENTIFIC DISCOVERIES AND IMPROVING PATIENT CARE TO DRIVE MARKET
TABLE 108 BIOBANKING MARKET FOR HUMAN TISSUES, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 CELL LINES
8.4.1 SERVE AS VALUABLE RESOURCES IN BIOBANKING
TABLE 113 BIOBANKING MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 ASIA PACIFIC: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 NUCLEIC ACIDS
8.5.1 GROWING DEMAND FOR STORAGE AND ANALYSIS OF NUCLEIC ACIDS TO DRIVE MARKET
TABLE 118 BIOBANKING MARKET FOR NUCLEIC ACIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 119 NORTH AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 LATIN AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 BIOLOGICAL FLUIDS
8.6.1 SERVE AS VALUABLE RESOURCES FOR RESEARCHERS AND CLINICIANS IN STUDYING DISEASES
TABLE 123 BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 HUMAN WASTE PRODUCTS
8.7.1 USE OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET
TABLE 128 BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION)
9 BIOBANKING MARKET, BY OWNERSHIP
9.1 INTRODUCTION
TABLE 133 BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
9.2 UNIVERSITIES
9.2.1 IMPORTANCE OF BIOBANKING IN ADVANCING RESEARCH TO DRIVE MARKET
TABLE 134 UNIVERSITY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NATIONAL/REGIONAL AGENCIES
9.3.1 SUSTAINED FUNDING AND STANDARDIZED PRACTICES TO SUPPORT MARKET GROWTH
TABLE 139 NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 140 NORTH AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 141 EUROPE: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 ASIA PACIFIC: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 LATIN AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 NON-PROFIT ORGANIZATIONS
9.4.1 FOCUS OF NON-PROFIT ORGANIZATIONS ON ADVANCING RESEARCH TO DRIVE MARKET
TABLE 144 NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 145 NORTH AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 146 EUROPE: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 ASIA PACIFIC: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 PRIVATE ORGANIZATIONS
9.5.1 INCREASING OWNERSHIP OF BIOBANKS BY PRIVATE ORGANIZATIONS TO DRIVE MARKET
TABLE 149 PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 150 NORTH AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 151 EUROPE: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 ASIA PACIFIC: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
10 BIOBANKING MARKET, BY APPLICATION
10.1 INTRODUCTION
TABLE 154 BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10.2 REGENERATIVE MEDICINE
10.2.1 INCREASING RESEARCH AND RISING GOVERNMENT FUNDING TO DRIVE MARKET
TABLE 155 BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 LATIN AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 LIFE SCIENCE RESEARCH
10.3.1 INCREASING DEMAND AND UTILIZATION OF BIOBANKS IN LIFE SCIENCE RESEARCH APPLICATIONS TO SUPPORT MARKET GROWTH
FIGURE 29 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
TABLE 160 BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 161 NORTH AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 LATIN AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 CLINICAL RESEARCH
10.4.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND ACCELERATED DRUG DEVELOPMENT TO PROPEL MARKET
TABLE 165 BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
11 BIOBANKING MARKET, BY END USER
11.1 INTRODUCTION
TABLE 170 BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
11.2.1 LARGEST END USER SEGMENT DUE TO GROWING NUMBER OF CLINICAL TRIALS AND RESEARCH STUDIES
TABLE 171 BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 172 NORTH AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ACADEMIC AND RESEARCH INSTITUTES
11.3.1 ADVANCEMENTS IN SCIENTIFIC RESEARCH AND INNOVATION TO DRIVE MARKET
TABLE 176 BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 178 EUROPE: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 179 ASIA PACIFIC: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 180 LATIN AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 HOSPITALS
11.4.1 USE BIOBANKING TO COLLECT, STORE, AND MANAGE PATIENT SAMPLES FOR DIAGNOSTIC PURPOSES
TABLE 181 BIOBANKING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
TABLE 182 NORTH AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 183 EUROPE: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 ASIA PACIFIC: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
12 BIOBANKING MARKET, BY REGION
12.1 INTRODUCTION
TABLE 186 BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
12.2.1 RECESSION IMPACT
FIGURE 30 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT
TABLE 187 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 NORTH AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 189 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 193 NORTH AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 194 NORTH AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 195 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 196 NORTH AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.2 US
12.2.2.1 Largest market in North America due to surge in genomic research
TABLE 197 US: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 198 US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 US: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 US: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 US: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 202 US: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 203 US: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 204 US: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 205 US: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.3 CANADA
12.2.3.1 Increasing number of biobanks to support market
TABLE 206 CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 207 CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 CANADA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 211 CANADA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 212 CANADA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 213 CANADA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 214 CANADA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3 EUROPE
12.3.1 RECESSION IMPACT
TABLE 215 EUROPE: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 216 EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 221 EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 222 EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 223 EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Largest market for biobanking in Europe
TABLE 225 GERMANY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 226 GERMANY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GERMANY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 GERMANY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 230 GERMANY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 231 GERMANY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 232 GERMANY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 233 GERMANY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 UK
12.3.3.1 Increasing number of biobanks to support market growth
TABLE 234 UK: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 235 UK: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 UK: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 237 UK: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 238 UK: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 239 UK: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 240 UK: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 241 UK: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 UK: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 FRANCE
12.3.4.1 Robust healthcare infrastructure and advanced research capabilities to propel market
TABLE 243 FRANCE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 244 FRANCE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 245 FRANCE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 246 FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 FRANCE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 248 FRANCE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 249 FRANCE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 250 FRANCE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 251 FRANCE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 ITALY
12.3.5.1 Emergence of private sector players to support market growth
TABLE 252 ITALY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 ITALY: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 ITALY: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 ITALY: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 257 ITALY: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 258 ITALY: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 259 ITALY: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 260 ITALY: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.6 SPAIN
12.3.6.1 Favorable government initiatives to propel market
TABLE 261 SPAIN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 262 SPAIN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 SPAIN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 264 SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 SPAIN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 266 SPAIN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 267 SPAIN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 268 SPAIN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 269 SPAIN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.7 REST OF EUROPE
TABLE 270 REST OF EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 271 REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 REST OF EUROPE: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 273 REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 274 REST OF EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 275 REST OF EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 276 REST OF EUROPE: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 277 REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 278 REST OF EUROPE: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4 ASIA PACIFIC
12.4.1 RECESSION IMPACT
FIGURE 31 ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT
TABLE 279 ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 280 ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 281 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 285 ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 286 ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 287 ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 288 ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.2 CHINA
12.4.2.1 Advanced healthcare infrastructure and increasing investments in medical research to propel market
TABLE 289 CHINA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 290 CHINA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 CHINA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 293 CHINA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 294 CHINA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 295 CHINA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 296 CHINA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 297 CHINA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 JAPAN
12.4.3.1 Advancements in medical research and increasing need for personalized medicine to drive market
TABLE 298 JAPAN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 299 JAPAN: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 300 JAPAN: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 JAPAN: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 303 JAPAN: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 304 JAPAN: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 305 JAPAN: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 306 JAPAN: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 INDIA
12.4.4.1 Demand for high-quality biological samples for medical research and development to drive market
TABLE 307 INDIA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 308 INDIA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 INDIA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 INDIA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 312 INDIA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 313 INDIA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 314 INDIA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 315 INDIA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 REST OF ASIA PACIFIC
TABLE 316 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 317 REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5 LATIN AMERICA
12.5.1 RECESSION IMPACT
TABLE 325 LATIN AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 326 LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 327 LATIN AMERICA BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 328 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 329 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 330 LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 331 LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 332 LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 333 LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 334 LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.2 BRAZIL
12.5.2.1 Advancements in research capabilities to favor market growth
TABLE 335 BRAZIL: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 336 BRAZIL: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 BRAZIL: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 339 BRAZIL: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 340 BRAZIL: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 341 BRAZIL: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 342 BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 343 BRAZIL: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 344 REST OF LATIN AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 345 REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 346 REST OF LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 347 REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 348 REST OF LATIN AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 349 REST OF LATIN AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 350 REST OF LATIN AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 351 REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 352 REST OF LATIN AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
12.6.1 INCREASING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET
12.6.2 RECESSION IMPACT
TABLE 353 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 354 MIDDLE EAST & AFRICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 355 MIDDLE EAST & AFRICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 356 MIDDLE EAST & AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 357 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION)
TABLE 358 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 359 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION)
TABLE 360 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 361 MIDDLE EAST & AFRICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 KEY PLAYER STRATEGIES IN BIOBANKING MARKET, JANUARY 2020–APRIL 2023
13.3 MARKET SHARE ANALYSIS
FIGURE 33 BIOBANKING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 362 BIOBANKING MARKET: DEGREE OF COMPETITION
13.4 REVENUE SHARE ANALYSIS
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 35 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT, 2022
13.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 36 BIOBANKING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2022
13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
TABLE 363 BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 364 BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
13.7.1 COMPANY FOOTPRINT ANALYSIS
TABLE 365 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS
13.7.2 END USER FOOTPRINT ANALYSIS
TABLE 366 END USER FOOTPRINT ANALYSIS OF KEY PLAYERS
13.7.3 REGIONAL FOOTPRINT ANALYSIS
TABLE 367 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
13.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 368 BIOBANKING MARKET: DEALS, JANUARY 2020–APRIL 2023
TABLE 369 BIOBANKING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020–APRIL 2023
TABLE 370 BIOBANKING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
14.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 371 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
14.1.2 PHC HOLDINGS CORPORATION
TABLE 372 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 38 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
14.1.3 BECTON, DICKINSON AND COMPANY
TABLE 373 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
14.1.4 QIAGEN N.V.
TABLE 374 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
14.1.5 MERCK KGAA
TABLE 375 MERCK KGAA: COMPANY OVERVIEW
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
14.1.6 AVANTOR, INC
TABLE 376 AVANTOR, INC.: COMPANY OVERVIEW
FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2022)
14.1.7 CRYOPORT, INC.
TABLE 377 CRYOPORT, INC.: COMPANY OVERVIEW
FIGURE 43 CRYOPORT, INC.: COMPANY SNAPSHOT (2022)
14.1.8 TECAN TRADING AG
TABLE 378 TECAN TRADING AG: COMPANY OVERVIEW
FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
14.1.9 AZENTA, INC.
TABLE 379 AZENTA, INC.: COMPANY OVERVIEW
FIGURE 45 AZENTA, INC.: COMPANY SNAPSHOT (2022)
14.1.10 GREINER AG
TABLE 380 GREINER AG: COMPANY OVERVIEW
FIGURE 46 GREINER AG: COMPANY SNAPSHOT (2021)
14.2 OTHER PLAYERS
14.2.1 HAMILTON COMPANY
14.2.2 MICRONIC
14.2.3 AMSBIO
14.2.4 BAY BIOSCIENCES LLC
14.2.5 BIOKRYO
14.2.6 SPT LABTECH
14.2.7 ASKION GMBH
14.2.8 CELL&CO BIOSERVICES
14.2.9 ZIATH LTD.
14.2.10 CTIBIOTECH
14.2.11 CURELINE
14.2.12 FIRALIS GROUP
14.2.13 SOPACHEM
14.2.14 PROTEOGENEX
14.2.15 US BIOLAB CORPORATION, INC.
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
